Literature DB >> 18188454

Pathogen-imposed skewing of mouse chemokine and cytokine expression at the infected tissue site.

Shoshana D Katzman1, Deborah J Fowell.   

Abstract

Compartmentalization of immunity ensures tight regulation of T cell activation in the LN and precise effector T cell delivery to inflamed sites. Herein we show that the tissue-specific accumulation of effector T cells can be subverted by a pathogen at the infection site. Using the Leishmania major mouse model of dermal infection, we observed a restricted chemokine profile at the infection site, i.e., the expression of Th2 cell-attracting CCL7 but not of Th1 cell-attracting chemokines. Consistent with these chemokine expression data, recruitment of cytokine-producing T cells to the infection site was also selective. Both IL-4- and IFN-gamma-producing effector T cells homed to inflamed OVA/CFA-immunized dermis, but only IL-4-producing cells homed to L. major-infected dermis. The narrowing of the cytokine repertoire at the site of infection with L. major was driven, in part, by pathogen-induced CCL7. Inflammatory signals failed to disrupt the early restrictive L. major infection site, which suggests that L. major dominantly modifies the local milieu. We have highlighted an emerging principle in pathogen-host interactions: that the cytokine repertoire at the infection site and the LN draining the infection site can be different because of the ability of the pathogen to modify the chemokine profile at the infection site. Thus, pathogens may edit the LN cytokine repertoire through differential recruitment of cytokine-producing cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18188454      PMCID: PMC2176190          DOI: 10.1172/JCI33174

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  69 in total

1.  A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity.

Authors:  Y Belkaid; S Mendez; R Lira; N Kadambi; G Milon; D Sacks
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

2.  Cutting edge: IL-12 is required for the maintenance of IFN-gamma production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii.

Authors:  G Yap; M Pesin; A Sher
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

3.  Granulocyte-macrophage colony-stimulating factor regulates effector differentiation of invariant natural killer T cells during thymic ontogeny.

Authors:  Jelena S Bezbradica; Laura E Gordy; Aleksandar K Stanic; Srdjan Dragovic; Timothy Hill; Jacek Hawiger; Derya Unutmaz; Luc Van Kaer; Sebastian Joyce
Journal:  Immunity       Date:  2006-08-31       Impact factor: 31.745

4.  Induction of a homeostatic circuit in lung tissue by microbial compounds.

Authors:  Kenji Takabayshi; Maripat Corr; Tomoko Hayashi; Vanessa Redecke; Lucinda Beck; Donald Guiney; Dean Sheppard; Eyal Raz
Journal:  Immunity       Date:  2006-04       Impact factor: 31.745

5.  Surface-bound chemokines capture and prime T cells for synapse formation.

Authors:  Rachel S Friedman; Jordan Jacobelli; Matthew F Krummel
Journal:  Nat Immunol       Date:  2006-09-10       Impact factor: 25.606

Review 6.  Dendritic cells: translating innate to adaptive immunity.

Authors:  R M Steinman; H Hemmi
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

7.  IL-12 is required to maintain a Th1 response during Leishmania major infection.

Authors:  A Y Park; B D Hondowicz; P Scott
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

8.  The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge.

Authors:  L Stobie; S Gurunathan; C Prussin; D L Sacks; N Glaichenhaus; C Y Wu; R A Seder
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

9.  Crucial role of MLL for the maintenance of memory T helper type 2 cell responses.

Authors:  Masakatsu Yamashita; Kiyoshi Hirahara; Ryo Shinnakasu; Hiroyuki Hosokawa; Satoko Norikane; Motoko Y Kimura; Akihiro Hasegawa; Toshinori Nakayama
Journal:  Immunity       Date:  2006-05       Impact factor: 31.745

10.  Leishmania major reaches distant cutaneous sites where it persists transiently while persisting durably in the primary dermal site and its draining lymph node: a study with laboratory mice.

Authors:  L Nicolas; S Sidjanski; J H Colle; G Milon
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

View more
  24 in total

Review 1.  Regulation of immunity at tissue sites of inflammation.

Authors:  Dorothy K Sojka; Christopher A Lazarski; Yu-Hui Huang; Irina Bromberg; Angela Hughson; Deborah J Fowell
Journal:  Immunol Res       Date:  2009-01-31       Impact factor: 2.829

2.  Accelerated healing of cutaneous leishmaniasis in non-healing BALB/c mice using water soluble amphotericin B-polymethacrylic acid.

Authors:  Karina Corware; Debra Harris; Ian Teo; Matthew Rogers; Kikkeri Naresh; Ingrid Müller; Sunil Shaunak
Journal:  Biomaterials       Date:  2011-07-31       Impact factor: 12.479

3.  Chronicity of dermal leishmaniasis caused by Leishmania panamensis is associated with parasite-mediated induction of chemokine gene expression.

Authors:  Adriana Navas; Deninson Alejandro Vargas; Marina Freudzon; Diane McMahon-Pratt; Nancy Gore Saravia; María Adelaida Gómez
Journal:  Infect Immun       Date:  2014-04-21       Impact factor: 3.441

4.  Mechanisms of immune evasion in leishmaniasis.

Authors:  Gaurav Gupta; Steve Oghumu; Abhay R Satoskar
Journal:  Adv Appl Microbiol       Date:  2013       Impact factor: 5.086

5.  SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine.

Authors:  Neelam Dhiman; Iana H Haralambieva; Richard B Kennedy; Robert A Vierkant; Megan M O'Byrne; Inna G Ovsyannikova; Robert M Jacobson; Gregory A Poland
Journal:  Immunogenetics       Date:  2010-03-10       Impact factor: 2.846

Review 6.  Role of chemokines in regulation of immunity against leishmaniasis.

Authors:  Steve Oghumu; Claudio M Lezama-Dávila; Angelica P Isaac-Márquez; Abhay R Satoskar
Journal:  Exp Parasitol       Date:  2010-03-03       Impact factor: 2.011

7.  Inflammatory chemokines and their receptors in human visceral leishmaniasis: Gene expression profile in peripheral blood, splenic cellular sources and their impact on trafficking of inflammatory cells.

Authors:  Neetu Singh; Shyam Sundar
Journal:  Mol Immunol       Date:  2017-02-20       Impact factor: 4.407

Review 8.  Signals for the execution of Th2 effector function.

Authors:  Deborah J Fowell
Journal:  Cytokine       Date:  2009-02-23       Impact factor: 3.861

9.  Keratinocytes determine Th1 immunity during early experimental leishmaniasis.

Authors:  Jan M Ehrchen; Kirsten Roebrock; Dirk Foell; Nadine Nippe; Esther von Stebut; Johannes M Weiss; Niels-Arne Münck; Dorothee Viemann; Georg Varga; Carsten Müller-Tidow; Hans-Joachim Schuberth; Johannes Roth; Cord Sunderkötter
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

10.  The CCL7-CCL2-CCR2 axis regulates IL-4 production in lungs and fungal immunity.

Authors:  Wendy A Szymczak; George S Deepe
Journal:  J Immunol       Date:  2009-07-08       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.